149 related articles for article (PubMed ID: 18822690)
1. Clinicopathological significance of overexpression of TSPAN1, Ki67 and CD34 in gastric carcinoma.
Chen L; Li X; Wang GL; Wang Y; Zhu YY; Zhu J
Tumori; 2008; 94(4):531-8. PubMed ID: 18822690
[TBL] [Abstract][Full Text] [Related]
2. Expression of CD34 in gastric cancer and its correlation with histology, stage, proliferation activity, p53 expression and apoptotic index.
Tenderenda M; Rutkowski P; Jesionek-Kupnicka D; Kubiak R
Pathol Oncol Res; 2001; 7(2):129-34. PubMed ID: 11458276
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis revealed CD34 and Ki67 protein expression as significant prognostic factors in colorectal cancer.
Ma YL; Peng JY; Zhang P; Liu WJ; Huang L; Qin HL
Med Oncol; 2010 Jun; 27(2):304-9. PubMed ID: 19340613
[TBL] [Abstract][Full Text] [Related]
4. Minichromosome maintenance 2 (MCM2) immunoreactivity in stage III human gastric carcinoma: clinicopathological significance.
Tokuyasu N; Shomori K; Nishihara K; Kawaguchi H; Fujioka S; Yamaga K; Ikeguchi M; Ito H
Gastric Cancer; 2008; 11(1):37-46. PubMed ID: 18373176
[TBL] [Abstract][Full Text] [Related]
5. Different significance between intratumoral and peritumoral lymphatic vessel density in gastric cancer: a retrospective study of 123 cases.
Wang XL; Fang JP; Tang RY; Chen XM
BMC Cancer; 2010 Jun; 10():299. PubMed ID: 20565772
[TBL] [Abstract][Full Text] [Related]
6. Constitutive phosphorylation of the FOXO1A transcription factor as a prognostic variable in gastric cancer.
Kim JH; Kim MK; Lee HE; Cho SJ; Cho YJ; Lee BL; Lee HS; Nam SY; Lee JS; Kim WH
Mod Pathol; 2007 Aug; 20(8):835-42. PubMed ID: 17491598
[TBL] [Abstract][Full Text] [Related]
7. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
[TBL] [Abstract][Full Text] [Related]
8. Expression of pRb, Ki67 and HER 2/neu in gastric carcinomas: Relation to different histopathological grades and stages.
Abdel-Aziz A; Ahmed RA; Ibrahiem AT
Ann Diagn Pathol; 2017 Oct; 30():1-7. PubMed ID: 28965621
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of p53 and Ki67 proteins expression in Greek gastric cancer patients.
Tzanakis NE; Peros G; Karakitsos P; Giannopoulos GA; Efstathiou SP; Rallis G; Tsigris C; Kostakis A; Nikiteas NI
Acta Chir Belg; 2009 Oct; 109(5):606-11. PubMed ID: 19994803
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological Significance of the Proliferation Markers Ki67, RacGAP1, and Topoisomerase 2 Alpha in Breast Cancer.
Şahin S; Işık Gönül İ; Çakır A; Seçkin S; Uluoğlu Ö
Int J Surg Pathol; 2016 Oct; 24(7):607-13. PubMed ID: 27284123
[TBL] [Abstract][Full Text] [Related]
11. Geminin, Ki67, and minichromosome maintenance 2 in gastric hyperplastic polyps, adenomas, and intestinal-type carcinomas: pathobiological significance.
Shomori K; Nishihara K; Tamura T; Tatebe S; Horie Y; Nosaka K; Haruki T; Hamamoto Y; Shiomi T; Nakabayashi M; Ito H
Gastric Cancer; 2010 Aug; 13(3):177-85. PubMed ID: 20820987
[TBL] [Abstract][Full Text] [Related]
12. High Ki67 Expression has Prognostic Value in Surgically-Resected T3 Gastric Adenocarcinoma.
Huang G; Chen S; Wang D; Wang R; Lin L; Chen S; Wang L; Huang Q
Clin Lab; 2016; 62(1-2):141-53. PubMed ID: 27012044
[TBL] [Abstract][Full Text] [Related]
13. Decreased histone H2B monoubiquitination in malignant gastric carcinoma.
Wang ZJ; Yang JL; Wang YP; Lou JY; Chen J; Liu C; Guo LD
World J Gastroenterol; 2013 Nov; 19(44):8099-107. PubMed ID: 24307806
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of DLX2 correlates with advanced stage of gastric adenocarcinoma.
Tang P; Huang H; Chang J; Zhao GF; Lu ML; Wang Y
World J Gastroenterol; 2013 May; 19(17):2697-703. PubMed ID: 23674878
[TBL] [Abstract][Full Text] [Related]
15. Potential prognostic significance of p185(HER2) overexpression with loss of PTEN expression in gastric carcinomas.
Im SA; Lee KE; Nam E; Kim DY; Lee JH; Han HS; Seoh JY; Park HY; Cho MS; Han WS; Lee SN
Tumori; 2005; 91(6):513-21. PubMed ID: 16457151
[TBL] [Abstract][Full Text] [Related]
16. Relationship between RGS5 expression and differentiation and angiogenesis of gastric carcinoma.
Wang JH; Huang WS; Hu CR; Guan XX; Zhou HB; Chen LB
World J Gastroenterol; 2010 Nov; 16(44):5642-6. PubMed ID: 21105200
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic characteristics of YES-associated protein 1 overexpression and its relationship to tumor biomarkers in gastric cancer.
Zhang J; Yang YC; Zhu JS; Zhou Z; Chen WX
Int J Immunopathol Pharmacol; 2012; 25(4):977-87. PubMed ID: 23298488
[TBL] [Abstract][Full Text] [Related]
18. MCM2 expression levels predict diagnosis and prognosis in gastric cardiac cancer.
Liu M; Li JS; Tian DP; Huang B; Rosqvist S; Su M
Histol Histopathol; 2013 Apr; 28(4):481-92. PubMed ID: 23329420
[TBL] [Abstract][Full Text] [Related]
19. TSPAN1 protein expression: a significant prognostic indicator for patients with colorectal adenocarcinoma.
Chen L; Zhu YY; Zhang XJ; Wang GL; Li XY; He S; Zhang JB; Zhu JW
World J Gastroenterol; 2009 May; 15(18):2270-6. PubMed ID: 19437569
[TBL] [Abstract][Full Text] [Related]
20. TSPAN1 functions as an oncogene in gastric cancer and is downregulated by miR-573.
Lu Z; Luo T; Nie M; Pang T; Zhang X; Shen X; Ma L; Bi J; Wei G; Fang G; Xue X
FEBS Lett; 2015 Jul; 589(15):1988-94. PubMed ID: 26054975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
